These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 135912)

  • 21. Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation.
    Grill V; Herberg L
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):561-6. PubMed ID: 6342326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucose and insulin on glucagon secretion in alloxan diabetic rats.
    Tanese T; Yokoyama J; Narimiya M; Tajima N; Yamada H; Ikeda Y; Abe M
    Horm Metab Res; 1980 Jul; 12(7):290-3. PubMed ID: 6995248
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucagon release from isolated pancreas in streptozotocin-treated rats.
    Buchanan KD; Mawhinney WA
    Diabetes; 1973 Nov; 22(11):797-800. PubMed ID: 4270690
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.
    Hope KM; Tran PO; Zhou H; Oseid E; Leroy E; Robertson RP
    Diabetes; 2004 Jun; 53(6):1488-95. PubMed ID: 15161753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T; Nakamura Y; Nakano K; Kondo M
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract]   [Full Text] [Related]  

  • 27. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL; Weir GC
    Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of A- and B-cell function by insulin and glucagon.
    Fujimoto WY; Ensinck JW
    Horm Metab Res; 1981 Oct; 13(10):547-50. PubMed ID: 7028587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microanatomy of the islets of Langerhans.
    Orci L
    Metabolism; 1976 Nov; 25(11 Suppl 1):1303-13. PubMed ID: 135911
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation of functional glucagon islets of Langerhans from the chicken pancreas.
    Ruffier L; Simon J; Rideau N
    Gen Comp Endocrinol; 1998 Nov; 112(2):153-62. PubMed ID: 9784298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adenosine triphosphate (ATP) and glucose. Action on insulin and glucagon secretion].
    Loubatières-Mariani MM; Loubatières AL; Chapal J; Valette G
    C R Seances Soc Biol Fil; 1976; 170(4):833-6. PubMed ID: 137051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic mice.
    Yen TT; Schmiegel KK; Gold G; Williams GD; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1991; 310():162-74. PubMed ID: 1772327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiologic, pathophysiologic and clinical interrelationships in diabetes.
    Williams RH
    Johns Hopkins Med J; 1975 Jan; 136(1):25-37. PubMed ID: 1092902
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of glucagon secretion by glucose and glyceraldehyde on isolated islets of Wistar rats.
    Hahn HJ; Ziegler M; Mohr E
    FEBS Lett; 1974 Dec; 49(1):100-2. PubMed ID: 4613572
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for an insulin-independent alpha-cell abnormality in human diabetes.
    Bennett PH; Aronoff SL; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1527-9. PubMed ID: 790099
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of glucagon secretion by nutrients in vitro.
    Matschinsky FM; Pagliara AS
    Metabolism; 1976 Nov; 25(11 Suppl 1):1435-6. PubMed ID: 185497
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disparity between the effect of glucose and arginine on insulin secretion from the perfused pancreas of non insulin dependent diabetic rats].
    Giroix MH; Portha B; Kergoat M; Picon L
    C R Seances Acad Sci III; 1981 Nov; 293(10):601-6. PubMed ID: 6800578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistin is produced by rat pancreatic islets and regulates insulin and glucagon in vitro secretion.
    Sassek M; Pruszynska-Oszmalek E; Kołodziejski PA; Szczepankiewicz D; Kaczmarek P; Wieloch M; Kurto K; Nogowski L; Nowak KW; Strowski MZ; Mackowiak P
    Islets; 2016 Nov; 8(6):177-185. PubMed ID: 27797297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.